MHRA review of levothyroxine products in response to concerns about potential inconsistencies of different products.
The review started in January 2011 and MHRA reviewed medical and scientific literature to assess:
- whether there could be differences in the bioavailability (extent/rate of absorption) of levothyroxine between different tablet products and/or batches
- what clinical implications this may have
- whether additional controls were needed